INVESTIGATION OF THE FAMILIAL HYPERCHOLESTEROLEMIA USING DISEASES-SPECIFIC INDUCED PLURIPOTENT STEM CELLS  by Okada, Hirofumi et al.
Stable Ischemic Heart Disease
A1628
JACC March 17, 2015
Volume 65, Issue 10S
investigation oF the Familial hyPerCholesterolemia using diseases-sPeCiFiC 
induCed PluriPotent stem Cells
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Molecular Biology Pathways of Cardiovascular Disease
Abstract Category: 25.  Stable Ischemic Heart Disease: Basic
Presentation Number: 1161-377
Authors: Hirofumi Okada, Chiaki Nakanishi, Shohei Yoshida, Masayuki Mori, Kenshi Hayashi, Tsuyoshi Yoshimuta, Hayato Tada, Masa-aki 
Kawashiri, Masakazu Yamagishi, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
Background: Familial hypercholesterolemia (FH) is known as a hereditary disease caused by the abnormality of a low-density lipoprotein 
receptor (LDLR) and a risk factor of premature atherosclerotic cardiovascular disease (ACVD). Many homozygous FH patients need the 
treatment of low-density lipoprotein (LDL) apheresis for prevention of ACVD, and the liver transplantation might be thought as radical 
therapy for them. Therefore alternative novel therapies are expected.
objective: The purpose of this study is to confirm effect of the functional abnormality of the LDLR using disease-specific human induced 
pluripotent stem cells (hiPSCs) and research the possibility of the novel therapies.
methods and results: We generated hiPSCs from a homozygous FH patient with mutation in the LDLR gene and two healthy control 
subjects. Then hepatocyte-like cells were differentiated from hiPSCs and identified as hepatocyte by evaluating the expression of 
albumin and alpha-1-antitrypsin. Though the difference was not seen in expression of LDLR among all cell lines, the uptake ability of LDL 
decreased only in FH-hiPSCs-derived hepatocytes. The comprehensive gene expression was examined using microarray in order to clarify 
the mechanism in detail that uptake ability of LDL decreased.
Conclusion:  We succeeded in construction of the disease model of the FH patient in vitro. We investigated possibility of the new treatment 
based on this result.
 
